Our CEO, Nigel Theobald, recently caught up with The Medicine Maker to discuss the story behind N4 Pharma and give his advice to entrepreneurs in the pharmaceutical industry. Click here to create your logins and read the full article.
N4 Pharma has been featured in the latest issue of BioPharm International.
We recently joined a full house of attendees at CrownBio’s annual conference.
Nigel Theobald, CEO of N4 Pharma, has spoken to Dr. Kevin Robinson at Manufacturing Chemist magazine about how the company has developed Nuvec® and the impact it could have for vaccines and cancer treatments.
N4 Pharma has been featured in the latest issue of SHARES Magazine.
A unique non-viral adjuvant delivery system for vaccines and cancer treatments.
Allan Hey, Head of CMC, N4 Pharma Ltd, gave a presentation on Nuvec® at the BioNow Oncology Conference on Wednesday 13th February.
N4 Pharma (LON:N4P) is a consumer-driven pharmaceutical company developing reformulations of a number of key drugs.
Download the Shares Spotlight pdf
Investors are spoiled for choice when it comes to small cap stocks with exciting events. As a taster for what’s to come in 2018, we’ve scoured the markets to look for some of the most interesting activities. Read on to discover 19 stocks either expecting big news in the [...]
